Tag: CPXX

BioTech, Services Sector, Software

Sonic Beats on Q2 Earnings, In Line on Revenue

Sonic (NASDAQ:SONC) reported Q2 earnings of $0.07 per share, up from $0.05 per share last year and a penny better than the analyst consensus on Capital IQ. System-wide same-store sales increased 1.4%, consisting of an increase of 1.5% at franchise drive-ins and an increase of 1.3% at company drive-ins. Total revenue was $109.7 million, down from $111.1 million last year and about in line with … Continue reading Sonic Beats on Q2 Earnings, In Line on Revenue

Mark DeFrance
Finance

Morning Movers: Celator Pharmaceuticals, Inc. (NASDAQ:CPXX), Atmel Corporation (NASDAQ:ATML), Home Loan Servicing Solutions, Ltd. (NASDAQ:HLSS), ON Semiconductor Corp. (NASDAQ:ONNN), Can-Fite BioPharma (NYSEMKT:CANF)

On Dec. 18, Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) announced that the application of European patent number 2,222,278 was allowed by the European Patent Office. The new patent, “Improved Taxane Delivery System,” covers the Company’s proprietary taxane prodrug nanoparticle delivery technology and CPX-8, a hydrophobic docetaxel prodrug nanoparticle, which is based on this innovative approach to drug delivery. Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) belongs to Healthcare sector. Its … Continue reading Morning Movers: Celator Pharmaceuticals, Inc. (NASDAQ:CPXX), Atmel Corporation (NASDAQ:ATML), Home Loan Servicing Solutions, Ltd. (NASDAQ:HLSS), ON Semiconductor Corp. (NASDAQ:ONNN), Can-Fite BioPharma (NYSEMKT:CANF)

Chris Lewis